NCEL
NewcelX Ltd.
NASDAQ: NCEL · HEALTHCARE · BIOTECHNOLOGY
$3.42
+2.09% today
Updated 2026-04-29
Market cap
$17.27M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.93
Dividend yield
—
52W range
$2 – $31
Volume
0.0M
NewcelX Ltd. (NCEL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.43M | $-2.73M | $-190009.00 | $-729386.00 | $-14.94M | $-13.88M | $-9.68M | $-4.27M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $4.00 | $39560.00 | $640000.00 | $4.00 | $3917.00 |
| Depreciation | — | $1.09M | — | $72.19M | $10050.00 | $11408.00 | $11408.00 | $3321.00 |
| Stock-based comp | $77.00 | — | — | — | $327000.00 | $22730.00 | $164906.00 | $125644.00 |
| Free cash flow | $-5.43M | $-2.73M | $-190009.00 | $-729390.00 | $-14.98M | $-14.52M | $-9.68M | $-4.27M |
| Investing cash flow | — | — | $-217252.00 | $225638.00 | $-39560.00 | $-3.51M | — | $-3917.00 |
| Financing cash flow | $6.73M | $557920.00 | $407479.00 | $503522.00 | $20.34M | $17.40M | $1.63M | $5.04M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |